Abstract:Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by platelet destruction resulting from autoantibodies against self-antigens and T-cell mediated cytotoxicity. Toll-like receptors (TLRs) are pattern recognition receptors important in mediating the immune response and their activation can lead to production of cytokines. Recent data suggest that TLR2 and TLR4 are crucial for the production of inflammatory cytokines and play central role in autoimmune diseases, yet little is known about their roles in ITP. Here we examined the gene expressions of TLR2 and TLR4 in ITP patients. We hypothesize that significant differences will exist between pre-treatment and post-treatment in ITP patients with similar changes reflected in the plasma concentration of cytokines. Total RNA was extracted from mononuclear cells obtained from 12 ITP patients and 15 healthy subjects. TLR2 and TLR4 mRNA expression levels were analyzed using a quantitative real-time PCR method and their protein expressions were validated by western blot. Plasma concentrations of cytokines IL-2, IFN-γ and TNF-α were measured by ELISA. Correlation analyses were carried out between the mRNA expression levels of TLR2 or TLR4 and the plasma levels of IL-2, IFN-γ and TNF-α. The gene expression of TLR2 and TLR4 were significantly increased in ITP patients comparing to healthy control group (p < 0.05 and p < 0.01, respectively). In addition their mRNA expression levels were decreased back into normal range after remission in 8 patients (p > 0.05, compared to healthy control group). Significantly positive correlations were found between the TLR2 mRNA expression level and the plasma concentration of IFN-γ or TNF-α (R = 0.75, p < 0.05; R = 0.83, p < 0.05, respectively). Changes in the gene expression of TLR4 and in the plasma concentration of IFN-γ or TNF-α were also significantly correlated (R = 0.82, p < 0.05; R = 0.88, p < 0.05, respectively). Directional changes in TLR2 / TLR4 and IFN-γ /TNF-α expression were concordant. However, there was no correlation found between TLR2 / TLR4 and IL-2. Differences in TLR2 and TLR4 expression strongly correlated with changes in IFN-γ and TNF-α suggest that the increased gene expressions of TLR2 and TLR4 in ITP patients may contribute to the pathophysiological progression of this disease by increasing the secretion of IFN-γ and TNF-α. Additional studies need to be performed to further clarify the role of TLRs -cytokines pathway in ITP.

Increased TRAIL Expression in Peripheral Blood Mononuclear Cells from Patients with Primary Immune Thrombocytopenia and Its Clinical Significance

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia

Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura Patients.

[Imbalance of Th17/Treg Cells Ratio in Peripheral Blood of Patients with Immune Thrombocytopenia].

Aberrant Expression of NLRP3, NLRC4 and NLRP6 Inflammasomes in Patients with Primary Immune Thrombocytopenia

Increased Expression Of Tlr2 And Tlr4 In Mononuclear Cells In Patient With Immune Thrombocytopenic Purpura

Alteration of Peripheral Blood B1 Cells and Its Associations with Condition and Prognosis of Idiopathic Thrombocytopenic Purpura Patients

Emerging role of stem cell memory-like T cell (TSCM) in immune thrombocytopenia.

Expression and Clinical Significance of miR-491-5p in Patients with Primary Immune Tombocytopenia

The Expression Profile of Toll-Like Receptor Signaling Molecules in Cd19(+) B Cells from Patients with Primary Immune Thrombocytopenia

Expression of miR-2 0 5 in the Peripheral Blood Mononuclear Cells from Patients with Primary Immune Thrombocytopenia

Excessive Expressions of T Cell Activation Markers in Pediatric Immune Thrombocytopenia

The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia.

Elevated Profiles of Th22 Cells and Correlations with Th17 Cells in Patients with Immune Thrombocytopenia

The Ratio of Treg/Th17 Cells Correlates with the Platelet Number in Different Disease State of Primary Immune Thrombocytopenia

Immune Checkpoint-Related Gene Polymorphisms Are Associated with Primary Immune Thrombocytopenia

Decreased expression of interleukin-27 in immune thrombocytopenia.

Protecting Minors from Tobacco Products: Public Interest Litigation Enables Enforcement in China

Th1 (CXCL10) and Th2 (CCL2) chemokine expression in patients with immune thrombocytopenia

Detection and Clinical Significance of Treg and Th1,Th2 Cells in Peripheral Blood of Patients with Immune Thrombocytopenia

Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications